UChicago Supports COVID-19 Research with Non-Exclusive, Royalty-Free License

Aerial view of the University of Chicago campus on September 23, 2017. (Photo by Drone Media Chicago)

The University of Chicago is committed to supporting the rapid development of new technologies and life-saving therapeutics in the battle against the coronavirus (COVID-19) pandemic.

A non-exclusive, royalty-free license will be made available, as applicable, along with the licensees’ commitment to support the development and distribution of innovations to prevent, diagnose, treat, and contain COVID-19 during the pandemic. This time-limited license is offered for any COVID-19-related inventions where legally possible.

The University of Chicago has joined other universities in signing AUTM’s COVID-19 Licensing Guidelines, which are in line with the association’s support for humanitarian licensing.

“At the Polsky Center for Entrepreneurship and Innovation, we help University of Chicago researchers bridge the gap between idea and impact – bringing innovations from the lab out into the world for the benefit of society,” said Bill Payne, executive director of Polsky Science and Technology.

“Today, this is needed more than ever amid the race to quickly and effectively develop and deploy new technologies and therapeutics to tackle the COVID-19 pandemic,” said Payne. “We look forward to your partnership during this unprecedented time.”

For more information, contact polskylicensing@uchicago.edu.

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.